Why India is the ‘Pharmacy’ of the Developing World
Developing countries
across the world face several challenges, key among which is providing their
people with affordable medicines of high-quality.
A ‘public
first’ approach to policy, strict medicine patent law and doctors wh have used
reverse-engineering to introduce generic drugs, are some of the reasons that
India has emerged as the ‘pharmacy’ of the developing world.
1. Millions of people around the world
rely on affordable medicines made in India to stay alive
Before 2005, India did not grant product patents on
medicines. This allowed for the production of low-cost, generic versions of
medicines that were patented in other countries.
Indian manufacturers, with their reverse engineering skills,
were the first to market low-cost versions of the life-saving cancer and HIV
drugs within a few years of their US launch. Robust competition among generic
producers in India has resulted in a price reduction of more than 99 percent
for medicines across different therapeutic areas, including Hepatitis C, HIV/AIDS,
Malaria, Tuberculosis and medicine for non-communicable diseases that are
critical for public health programmes.
2. Access to affordable HIV treatment
from India is one of the greatest success stories in medicine
Big pharmaceutical corporations with patent monopolies were
charging over $10,00 per patient per year for antiretrovirals, thereby making
treatment economically unviable for millions of patients in the developing
world.
Dr. Yussef Hamied from India electrified the world by announcing
that the generic company Cipla would manufacture and supply the triple
fixed-dose combination of HIV antiretorvirals at $1 a day, a 99.99 percent
price cut.$1 a day, a 99.99 percent price cut.
Today, India is the world’s primary source of affordable HIV
medicines as it is one of the few countries with the capacity to quickly
produce newer HIV drugs as generics.
Governments of developing countries have also initiated HIV treatment
programmes using generically produced medicines from India. These programmes
benefit more than 15 million people who are living with HIV/ AIDS.
3. India is one of the biggest suppliers
of low-cost vaccines in the world
The recombinant Hepatitis B vaccine is an excellent example
of one of India’s low cost medicines. Large multinational pharmaceutical
companies held a complete monopoly on the vaccine and ensured that the price of
the drug was high. At $23 per dose, a manufacturer in India saw an unmet need
and, in the absence of patent barriers, developed a Hepatitis B vaccine to
reduce the price of the drug to less than $1 per dose. Today India is a main
supplier of vaccines to UNICEF and to the Ministries of Health in numerous
countries.
Comments
Post a Comment